Back to Search
Start Over
Correction to: Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases.
- Source :
- Digestive Diseases & Sciences; Dec2019, Vol. 64 Issue 12, p3674-3675, 2p
- Publication Year :
- 2019
-
Abstract
- The original version of the article unfortunately contained a couple of errors. In 'methods' section, in 'Outcomes' subsection, the sentence 'Endoscopic remission was defined as an SESCD ≤ 2 in patients with CD and an EMS ≤ 2 in UC patients while off corticosteroids.' [ABSTRACT FROM AUTHOR]
- Subjects :
- INFLAMMATORY bowel diseases
VEDOLIZUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 01632116
- Volume :
- 64
- Issue :
- 12
- Database :
- Complementary Index
- Journal :
- Digestive Diseases & Sciences
- Publication Type :
- Academic Journal
- Accession number :
- 139691401
- Full Text :
- https://doi.org/10.1007/s10620-019-05876-0